National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients With Type 2 Diabetes: The FINE-Asia Registry
Diabetes Therapy - United States
doi 10.1007/s13300-015-0137-8
Full Text
Open PDFAbstract
Available in full text
Date
October 14, 2015
Authors
Publisher
Springer Science and Business Media LLC